이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

편집증의 변동성 (VIP)

2026년 9월 25일 업데이트: Julia Sheffield, Vanderbilt University Medical Center

박해 망상에서 신념 업데이트의 역할을 테스트합니다

The goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals with schizophrenia-spectrum disorders.

The main questions are:

  1. do prior expectations about environmental volatility reduce following effective psychotherapeutic treatment of delusions?
  2. does corresponding brain activity related to volatility change with effective treatment of delusions?

Participants will:

  1. engage in CBTp or TAU + phone check-ins for 16 weeks
  2. complete assessments at 4 timepoints over the course of 6 months
  3. complete an MRI when possible

연구 개요

연구 유형

중재적

등록 (추정된)

120

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Tennessee
      • Nashville, Tennessee, 미국, 37212
        • 모병
        • Vanderbilt University Medical Center
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Men and women age 18 - 65.
  • Communicative in English.
  • Premorbid IQ >79 (WTAR)
  • Provide voluntary, written informed consent.
  • Stable medication regimen over at least the past two weeks, including the use of either an oral or intramuscular administration of an antipsychotic medication.
  • Diagnosis of a non-affective psychotic disorder (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder)
  • A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic Symptoms Rating Scale (PSYRATS) that had persisted for at least two months and that was not considered the direct result of substance use.

Exclusion Criteria:

  • Serious medical or neurological illness known to interfere with cognitive functioning (uncontrolled/unstable diabetes, uncontrolled hypothyroidism, Cushing's disease, Lupus, any demyelinating disease such as Multiple Sclerosis, HIV infection, CNS infection, unstable heart disease, active hepatitis, other significant endocrine condition, any cancer involving the CNS/brain, any uncorrected vision problems, tardive dyskinesia).
  • History of severe head trauma with loss of consciousness >30 minutes.
  • Primary diagnosis of alcohol or substance use disorder or personality disorder

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: CBTp

Weekly individual psychotherapy targeting specific maintenance factors of paranoia (worry, anomalous experiences, self-confidence, and safety behaviors), tailored to the participant's experience

Individuals will be assessed for which psychological factors are maintaining paranoia in their daily lives. They will collaboratively identify one maintenance factor to focus on (e.g. worry, anomalous experience, self-confidence, PTSD) for 8 weeks of individual therapy. Then, all participants will transition to 8 weeks of individual therapy focused on dropping safety behaviors and re-engaging in everyday life.

활성 비교기: TAU + Phone Check-In

Participants will continue with their regular care (treatment as usual (TAU)) without interference from the study team. In addition to TAU, a study therapist will call them weekly to review what treatment the participants have engaged in. Phone calls will last approximately 5-10 minutes

Individuals will continue treatment as usual (TAU). In addition they will have contact with a study therapist weekly via phone to provide information on what treatment they received. Phone check-ins will last approximately 5-10 minutes.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in prior expectations of volatility (mu3)
기간: Baseline to 16 weeks

Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the prior expectations of environmental volatility. That parameter, in many models, is Mu3.

Baseline to 16 weeks
Change in unexpected uncertainty (kappa)
기간: Baseline to 16 weeks

Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the unexpected uncertainty, sometimes also referred to as sensitivity to volatility.

Baseline to 16 weeks
Change in psychotic Symptom Rating Scale (PSYRATS)- Belief Subscale Total
기간: Baseline to 16 weeks

The PSYRATS is a interview-assisted assessment measuring the severity of a delusional belief. Total scores range from 0-24 with high scores indicating more severe delusion; 6 questions, 0-4 scale for each item

Baseline to 16 weeks
Change in PANSS Positive Symptoms - Total
기간: Baseline to 16 weeks

The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. The positive symptom total score is the sum of the Positive Symptom items

Baseline to 16 weeks
BOLD activation change during PRL task, pre/post treatment - prefrontal cortex
기간: Baseline to 16 weeks

functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group

Baseline to 16 weeks
BOLD activation change pre/post treatment - striatum
기간: Baseline to 16 weeks

functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group

Baseline to 16 weeks
BOLD activation change during PRL task, pre/post treatment - locus coeruleus
기간: Baseline to 16 weeks

functional MRI will be used to collect BOLD activation data during the PRL reversal learning task. The investigators expect changes in activation following treatment, particularly in the CBTp group

Baseline to 16 weeks
Task-based functional connectivity changes during PRL task, pre/post treatment - prefrontal cortex to striatum
기간: Baseline to 16 weeks

Functional connectivity during the PRL task will be quantified between the dlPFC and striatum

Baseline to 16 weeks
Volatility Expectations - During Stable3 Task
기간: Change from baseline
Change from baseline
Scale of Unpredictability Beliefs
기간: Change from baseline
Change from baseline

2차 결과 측정

결과 측정
측정값 설명
기간
PRL 작업 중에 대담한 활성화 변경, 사전/후 치료 - 전체 뇌 분석
기간: 기준선에서 16 주
기준선에서 16 주
Change in PANSS P1 Item
기간: Baseline to 16 weeks

The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. P1 is the first item on the scale, representing delusion severity

Baseline to 16 weeks
Change in PANSS P6 Item
기간: Baseline to 16 weeks

The PANSS is a 30-item clinician-rated instrument for assessing schizophrenia symptoms. It consists of 3 subscales: positive subscale (7 items), negative subscale (7 items), and general psychopathology subscale (16 items). For each item, symptom severity was rated on a 7-point scale, from 1=absent to 7=extreme. The PANSS total score for each participant was sum of the rating assigned to each of the 30 PANSS items, and ranged from 30 to 210 with a higher score indicating greater severity of symptoms. P6 is the item on the scale assessing severity of paranoia/suspiciousness

Baseline to 16 weeks
Change in meta-volatility learning rate (omega3)
기간: Baseline to 16 weeks

Reversal learning data will be collected from a 3-option probabilistic reversal learning task. This data will be analyzed using a computational model that estimates the meta-volatility.

Baseline to 16 weeks
PSYRATS Hallucinations
기간: Change from baseline
Change from baseline
Kamin Blocking
기간: Change from baseline
Change from baseline
Social Hallucinations - Chasing
기간: Change from baseline
Change from baseline
Minnesota Trust Game
기간: Change from baseline
Change from baseline
r-GPTS
기간: Change from baseline
Change from baseline
DWQ
기간: Change from baseline
Change from baseline
BDI-II
기간: Change from baseline
Change from baseline
O-AS
기간: Change from baseline
Change from baseline
Positive Thoughts Scale
기간: Change from baseline
Change from baseline
Guilt and Shame Experiences Scale
기간: Change from baseline
Change from baseline
O-CDQ
기간: Change from baseline
Change from baseline
Insomnia Severity Index
기간: Change from baseline
Change from baseline
PCL-5
기간: Change from baseline
Change from baseline
CEFSA
기간: Change from baseline
Change from baseline
DERS-16
기간: Change from baseline
Change from baseline
Intolerance of Uncertainty
기간: Change from baseline
Change from baseline
LSAS
기간: Change from baseline
Change from baseline
LSNS-6
기간: Change from baseline
Change from baseline
CHOICE
기간: Change from baseline
Change from baseline
WEMWBS
기간: Change from baseline
Change from baseline
MCQ-36
기간: Change from baseline
Change from baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 1월 15일

기본 완료 (추정된)

2029년 9월 3일

연구 완료 (추정된)

2030년 2월 1일

연구 등록 날짜

최초 제출

2025년 2월 12일

QC 기준을 충족하는 최초 제출

2025년 2월 12일

처음 게시됨 (실제)

2025년 2월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 30일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 25일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다